SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-05 |
| Reported value | $177,424,615 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PHATHOM PHARMACEUTICALS INC | PHAT | COM | $80,990,606 | 7,464,572 |
| NEWAMSTERDAM PHARMA COMPANY | NAMS | ORDINARY SHARES | $74,850,776 | 2,208,639 |
| AURA BIOSCIENCES INC | AURA | COM | $21,583,233 | 3,039,892 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.